Neuland Laboratories Limited (NSE:NEULANDLAB)
India · Delayed Price · Currency is INR 14,500
+534 (3.82%)
Sep 29, 2025, 3:29 PM IST
Neuland Laboratories Market Cap
Neuland Laboratories has a market cap or net worth of 179.03 billion as of September 29, 2025. Its market cap has increased by 11.74% in one year.
Market Cap
179.03B
Enterprise Value
178.21B
Revenue
13.30B
Ranking
n/a
PE Ratio
101.65
Stock Price
14,500.00
Market Cap Chart
Since December 18, 2000, Neuland Laboratories's market cap has increased from 335.14M to 179.03B, an increase of 53,320.74%. That is a compound annual growth rate of 28.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 179.03B | 1.65% |
| Dec 31, 2024 | 176.13B | 159.63% |
| Dec 29, 2023 | 67.84B | 216.90% |
| Dec 30, 2022 | 21.41B | 7.77% |
| Dec 31, 2021 | 19.86B | 41.44% |
| Dec 31, 2020 | 14.04B | 161.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,807.02B |
| Divi's Laboratories | 1,510.38B |
| Cipla | 1,211.15B |
| Apollo Hospitals Enterprise | 1,079.82B |
| Mankind Pharma | 1,024.84B |
| Zydus Lifesciences | 981.08B |
| Fortis Healthcare | 704.19B |
| Alkem Laboratories | 649.60B |